Next, we investigated whether IL-33 can induce Tff1-Tregs in vivo. Intranasal administration of IL-33 has been shown to induce pulmonary inflammation including the accumulation of eosinophils, resulting in asthma (28, 29). This evidence concerns the gene TFF1 and inflammatory response.